Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 32.98%1.57B | 26.74%1.07B | 38.54%448.17M | -22.80%2.4B | -15.36%1.18B | 1.98%844.66M | 8.75%323.51M | 3.55%3.11B | -11.07%1.39B | -7.31%828.3M |
| Refunds of taxes and levies | 53.91%11.4M | 20.65%7.97M | 2.64%5.52M | -51.68%10.22M | -60.20%7.4M | -54.49%6.61M | -43.67%5.38M | -6.11%21.15M | -4.67%18.6M | -14.18%14.51M |
| Cash received relating to other operating activities | -23.92%37.13M | -26.00%24.68M | -14.96%11.52M | -12.25%86.66M | -2.70%48.81M | -11.21%33.35M | -1.57%13.54M | 78.39%98.75M | 89.85%50.16M | 60.56%37.56M |
| Cash inflows from operating activities | 30.86%1.62B | 24.71%1.1B | 35.86%465.21M | -22.66%2.5B | -15.49%1.23B | 0.48%884.62M | 6.74%342.43M | 4.83%3.23B | -9.33%1.46B | -5.73%880.38M |
| Goods services cash paid | -13.40%1.13B | -26.17%635.33M | -21.49%337.67M | 25.44%1.9B | 22.89%1.3B | 21.15%860.57M | 26.25%430.08M | -17.26%1.52B | -27.59%1.06B | -37.21%710.32M |
| Staff behalf paid | -17.32%506.54M | -20.07%362.48M | -29.63%205.68M | 1.00%743.08M | 8.01%612.63M | 18.00%453.52M | 37.04%292.3M | 2.30%735.75M | 16.62%567.22M | 12.80%384.34M |
| All taxes paid | -15.00%110.02M | -22.42%96.23M | -34.42%69.52M | -41.31%137.76M | -37.58%129.43M | -7.33%124.05M | 52.17%106.01M | 70.76%234.72M | 155.80%207.35M | 113.64%133.86M |
| Cash paid relating to other operating activities | 4.09%132.9M | 7.45%89.77M | 25.79%38.11M | 27.66%180.92M | 55.87%127.68M | 71.31%83.55M | 36.42%30.3M | 194.82%141.72M | 32.26%81.92M | 42.41%48.77M |
| Cash outflows from operating activities | -13.57%1.88B | -22.20%1.18B | -24.19%650.98M | 12.77%2.97B | 13.36%2.17B | 19.13%1.52B | 32.96%858.69M | -3.99%2.63B | -8.45%1.92B | -18.58%1.28B |
| Net cash flows from operating activities | 72.00%-262.76M | 87.34%-80.64M | 64.02%-185.77M | -178.69%-470.03M | -105.72%-938.52M | -60.51%-637.07M | -58.83%-516.26M | 76.08%597.32M | 5.50%-456.2M | 37.48%-396.91M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 0.00%700M | --700M | ---- | -3.01%1.4B | -5.80%700M | ---- | ---- | -0.47%1.44B | 35.04%743.07M | 179.73%700M |
| Cash received from returns on investments | -20.00%11.35M | --11.35M | ---- | -17.59%20.24M | -0.73%14.19M | ---- | ---- | 30.61%24.56M | 93.72%14.3M | 562.63%14.3M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -86.96%1.12K | ---- | ---- | 7,245.41%138.09K | --8.57K | --8.57K | --478.63 | -94.53%1.88K | ---- | ---- |
| Cash inflows from investing activities | -0.40%711.35M | 8,302,092.33%711.35M | ---- | -3.24%1.42B | -5.70%714.2M | -100.00%8.57K | -99.97%478.63 | -0.08%1.47B | 35.81%757.37M | 182.99%714.3M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -29.32%50.47M | -29.12%35.83M | -30.36%19.16M | 6.21%95.72M | 4.49%71.4M | 12.94%50.54M | -1.88%27.51M | -6.96%90.13M | -2.33%68.33M | -12.06%44.75M |
| Cash paid to acquire investments | 14.29%800M | ---- | ---- | 0.00%1.4B | 0.00%700M | ---- | ---- | -34.88%1.4B | -43.55%700M | ---- |
| Cash outflows from investing activities | 10.25%850.47M | -29.12%35.83M | -30.36%19.16M | 0.38%1.5B | 0.40%771.4M | 12.94%50.54M | -1.88%27.51M | -33.68%1.49B | -41.35%768.33M | -94.89%44.75M |
| Net cash flows from investing activities | -143.21%-139.11M | 1,436.74%675.53M | 30.36%-19.16M | -239.56%-75.35M | -421.96%-57.2M | -107.55%-50.54M | -4.85%-27.51M | 97.15%-22.19M | 98.54%-10.96M | 207.35%669.54M |
| Financing cash flow | ||||||||||
| Dividend interest payment | 0.41%50.74M | ---- | ---- | 0.90%50.81M | 0.34%50.53M | -72.26%57.53K | --57.53K | 20.14%50.36M | 17.23%50.36M | --207.43K |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | --57.53K | --57.53K | --57.53K | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | -35.98%22M | 79.03%18.52M | -49.71%2.81M | -20.85%38.92M | -7.93%34.36M | -44.81%10.34M | -62.46%5.59M | -52.54%49.17M | 668.41%37.32M | 507.98%18.74M |
| Cash outflows from financing activities | -14.32%72.74M | 78.04%18.52M | -50.23%2.81M | -9.84%89.73M | -3.18%84.89M | -45.11%10.4M | -62.07%5.65M | -31.61%99.53M | 83.37%87.68M | 514.71%18.95M |
| Net cash flows from financing activities | 14.32%-72.74M | -78.04%-18.52M | 50.23%-2.81M | 9.84%-89.73M | 3.18%-84.89M | 45.11%-10.4M | 62.07%-5.65M | 29.22%-99.53M | -83.37%-87.68M | -514.71%-18.95M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | 56.08%-474.61M | 182.57%576.37M | 62.19%-207.73M | -233.54%-635.11M | -94.76%-1.08B | -375.15%-698.01M | -50.05%-549.41M | 182.12%475.6M | 56.75%-554.84M | 120.11%253.68M |
| Add:Begin period cash and cash equivalents | -24.65%1.94B | -24.65%1.94B | -24.65%1.94B | 22.63%2.58B | 22.63%2.58B | 22.63%2.58B | 22.63%2.58B | -21.61%2.1B | -21.61%2.1B | -21.61%2.1B |
| End period cash equivalent | -1.95%1.47B | 34.02%2.52B | -14.47%1.73B | -24.65%1.94B | -3.24%1.5B | -20.22%1.88B | 16.85%2.03B | 22.63%2.58B | 10.66%1.55B | 65.98%2.35B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.